What does Research Specialties for Laboratories do?

Research Specialties for Laboratories is registered with the CBE as active in: Vervaardiging van andere chemische producten, neg. Public Limited, started on 24 September 1976, 1 establishment.

What is the address of Research Specialties for Laboratories?

The registered office of Research Specialties for Laboratories is located at Begoniastraat 5, 9810 Nazareth-De Pinte.

Is Research Specialties for Laboratories still active?

Yes. According to the CBE (30 October 2026) Research Specialties for Laboratories is active, legal situation “Normale toestand”, started on 24 September 1976.

Is Research Specialties for Laboratories registered on Peppol?

Yes, Research Specialties for Laboratories is registered on the Peppol network with ID 0208:0416414367.

What is the enterprise number of Research Specialties for Laboratories?

The enterprise number of Research Specialties for Laboratories is BE0416414367.

When was Research Specialties for Laboratories founded?

Research Specialties for Laboratories was founded on 24 September 1976.

Who are the directors of Research Specialties for Laboratories?

According to the 2024 annual accounts, the directors of Research Specialties for Laboratories are: Anthony FONG, Norman SCHWARTZ.

Is Research Specialties for Laboratories a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 September 1976; 5 annual accounts filed, latest fiscal year 2024; 2 directors known from the annual account.

How much profit did Research Specialties for Laboratories make in 2024?

Research Specialties for Laboratories posted a profit after taxes of € 140,677 in financial year 2024.

What is the revenue of Research Specialties for Laboratories?

In its most recent annual accounts (2024), Research Specialties for Laboratories reported revenue of € 7,180,854.

How much does an employee at Research Specialties for Laboratories earn?

The average wage cost per full-time employee at Research Specialties for Laboratories was € 84,100 in 2024: staff costs of € 2.3 million for 27 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Research Specialties for Laboratories have?

According to the 2024 annual accounts, Research Specialties for Laboratories has 27 full-time equivalents (FTE).

Does Research Specialties for Laboratories have a website?

Yes, Research Specialties for Laboratories has a website at bio-rad.com.

Research Specialties for Laboratories (Public Limited)

Dossier Research Specialties for Laboratories, printed on 30 October 2026 from databakkes.be/en/0416414367/research-specialties-for-laboratories. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Research Specialties for Laboratories from Nazareth-De Pinte, company number BE0416414367, closed financial year 2024 with a result of € 140,677 after tax. For that financial year Research Specialties for Laboratories recorded revenue of € 7.2 million and equity of € 6 million. Compared with financial year 2023, the result moved from € 360,424 to € 140,677. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on November 4, 2025.

What it is worth Growing

€ 6 million

▲ 2% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 140,677

▼ 61% vs 2023

Profit after tax over the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 5 million.

People and assets in 2024

Full-time equivalents

▲ 1.8 vs 2023

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 2.3 million

▲ 7% vs 2023

€ 84,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 30,857

▲ 12% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

€ 28

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 864,175

▼ 71% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 399,023

▲ 108% vs 2023

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Revenue	-	-	-	€ 7,180,854 Revenue 2024: € 7,180,854 First fiscal year in the series
Gross margin	€ 2,727,567 Gross margin 2021: € 2,727,567 First fiscal year in the series	€ 2,379,051 Gross margin 2022: € 2,379,051 ▼ 13% vs 2021 (€ 2,727,567) Unfavourable step	€ 2,490,970 Gross margin 2023: € 2,490,970 ▲ 5% vs 2022 (€ 2,379,051) Favourable step	€ 2,607,553 Gross margin 2024: € 2,607,553 ▲ 5% vs 2023 (€ 2,490,970) Favourable step	▲ 5%
Profit after taxes	€ 318,296 Profit after taxes 2021: € 318,296 First fiscal year in the series	€ 363,243 Profit after taxes 2022: € 363,243 ▲ 14% vs 2021 (€ 318,296) Favourable step	€ 360,424 Profit after taxes 2023: € 360,424 ▼ 1% vs 2022 (€ 363,243) Unfavourable step	€ 140,677 Profit after taxes 2024: € 140,677 ▼ 61% vs 2023 (€ 360,424) Unfavourable step	▼ 61%
Equity	€ 5,170,219 Equity 2021: € 5,170,219 First fiscal year in the series	€ 5,533,462 Equity 2022: € 5,533,462 ▲ 7% vs 2021 (€ 5,170,219) Favourable step	€ 5,893,886 Equity 2023: € 5,893,886 ▲ 7% vs 2022 (€ 5,533,462) Favourable step	€ 6,034,563 Equity 2024: € 6,034,563 ▲ 2% vs 2023 (€ 5,893,886) Favourable step	▲ 2%
Total debts	€ 3,874,580 Total debts 2021: € 3,874,580 First fiscal year in the series	€ 2,848,372 Total debts 2022: € 2,848,372 ▼ 26% vs 2021 (€ 3,874,580) Favourable step	€ 3,129,128 Total debts 2023: € 3,129,128 ▲ 10% vs 2022 (€ 2,848,372) Unfavourable step	€ 1,263,226 Total debts 2024: € 1,263,226 ▼ 60% vs 2023 (€ 3,129,128) Favourable step	▼ 60%
Cash	€ 1,003,567 Cash 2021: € 1,003,567 First fiscal year in the series	€ 933,526 Cash 2022: € 933,526 ▼ 7% vs 2021 (€ 1,003,567) Unfavourable step	€ 0 Cash 2023: € 0 ▼ 100% vs 2022 (€ 933,526) Unfavourable step	-
Retained profit	€ 4,178,645 Retained profit 2021: € 4,178,645 First fiscal year in the series	€ 4,541,888 Retained profit 2022: € 4,541,888 ▲ 9% vs 2021 (€ 4,178,645) Favourable step	€ 4,902,312 Retained profit 2023: € 4,902,312 ▲ 8% vs 2022 (€ 4,541,888) Favourable step	€ 5,042,989 Retained profit 2024: € 5,042,989 ▲ 3% vs 2023 (€ 4,902,312) Favourable step	▲ 3%
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 26,432 Bank debt 2022: € 26,432 Unchanged (€ 0) Unfavourable step	€ 28 Bank debt 2023: € 28 ▼ € 26,404 vs 2022 (€ 26,432) Favourable step	€ 28 Bank debt 2024: € 28 Unchanged (€ 28) Unchanged
Balance sheet total	€ 9,044,798 Balance sheet total 2021: € 9,044,798 First fiscal year in the series	€ 8,381,834 Balance sheet total 2022: € 8,381,834 ▼ 7% vs 2021 (€ 9,044,798) Unchanged	€ 9,023,014 Balance sheet total 2023: € 9,023,014 ▲ 8% vs 2022 (€ 8,381,834) Unchanged	€ 7,297,789 Balance sheet total 2024: € 7,297,789 ▼ 19% vs 2023 (€ 9,023,014) Unchanged	▼ 19%
Employees (FTE)	25.6 Employees (FTE) 2021: 25.6 First fiscal year in the series	18.8 Employees (FTE) 2022: 18.8 ▼ 6.8 vs 2021 (25.6) Unchanged	25.2 Employees (FTE) 2023: 25.2 ▲ 6.4 vs 2022 (18.8) Unchanged	27 Employees (FTE) 2024: 27 ▲ 1.8 vs 2023 (25.2) Unchanged	▲ 1.8

Key figures of Research Specialties for Laboratories, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Research Specialties for Laboratories?

What happened at Research Specialties for Laboratories in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

2029 Anthony FONG stepped down as director. NBB
2027 Norman SCHWARTZ stepped down as director. NBB
Nov 4, 2025 New annual accounts for financial year 2024: profit of € 140,677 (▼ 61% vs 2023). filed late Source: NBB ↗
2023 Anthony FONG became a director. NBB
2021 Norman SCHWARTZ became a director. NBB
Oct 7, 1976 New establishment in Nazareth-De Pinte. KBO
Sep 24, 1976 Start of the company according to the CBE. KBO

In short

From € 318,296 profit in 2021 to € 140,677 profit in 2024.

Paid € 31,151 in corporate taxes since 2021.

Best year ever: 2022, with € 363,243 profit.

On average € 96,600 of value added per employee in 2024.

Original PDFs at the National Bank ↗

Management

Directors

According to the 2024 annual accounts

Anthony FONG

Director

since 2023 · until 2029

Norman SCHWARTZ

Director

since 2021 · until 2027

Establishments

Establishment units

Physical locations of this company

Registered office

Begoniastraat 5

9810 Nazareth-De Pinte

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS bio-rad.com

Canonical: https://www.bio-rad.com/en-be

Technologies

ASP.NETDrupalNginxWistiajQuery

Certifications & Partners

BRC

Hosting & Email

Email provider

Microsoft 365

Hosting

AMAZON-02 - Amazon.com, Inc., US

DNS

AWS Route 53

Domain

bio-rad.com

Registered

1991-07-11

Registrar

CSC Corporate Domains, Inc.

Expires

2026-07-10

Website info

HTTPS Ja

Languages EN

Features

Webshop Contact page

Security

✓ HTTPS

✗ SPF

✓ DMARC

Network

✓ Load balancing

Details

Company number

0416.414.367

VAT number

BE 0416.414.367

Registered office

Begoniastraat 5, 9810 Nazareth-De Pinte

Names & denominations

Research Specialties for Laboratories · R.S.L.

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

24 September 1976

Peppol

Active · Active since 25 Mar 2026

Contact

bio-rad.com +1-800-424-6723

Activities · NACE

Vervaardiging van andere chemische producten, neg

Vervaardiging van fotochemische producten

View on CBE Public ↗ Annual accounts (NBB) ↗

Research Specialties for Laboratories